No Deal Yet On National Drug Track-And-Trace System

Law360, New York (May 22, 2012, 7:39 PM EDT) -- Drug industry stakeholders and lawmakers have yet to come to a final agreement on a nationwide system for tracking pharmaceuticals, but said Tuesday that they expect to reach a deal in time to include it in the U.S. Food and Drug Administration user fee bill.

The track-and-trace proposal, developed by a range of industry stakeholders, is a major piece of unfinished business in the user fee bill. On Monday, Senate health committee leaders filed a final version on the bill, which leaders hope to vote on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.